Experiment 572050

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVO

Compounds isolated

THAPSIGARGIN

Details

PropertyValue
Pharmacology
TUMOR PROMOTING EFFECT
Administration routeEXTERNAL
OrganismEmpty organism
CitationLOWRY,DT: LI,LW: HENNINGS,H:. (1996). THAPSIGARGIN, A WEAK SKIN TUMOR PROMOTER, ALTERS THE GROWTH AND DIFFERENTIATION OF MOUSE KERATINOCYTES IN CULTURE.. 17(4)
Amount utilized
Compound isolated
DiseaseDOSED TWICE WEEKLY X30, AFTER DMBA INITIATION. TPA INHIBITED EFFECT.
Dose amount5.0 MCG
Number1
Qualitative resultACTIVE
AnimalMOUSE
Per unitANIMAL
Dose expressionDOSE